This international conference at Maastricht University explores how artificial intelligence is reshaping the pharmaceutical sector. Speakers from academia, regulatory authorities and industry will discuss developments in research and development, medicines regulation, data and real-world evidence, intellectual property, market access and pharmaceutical policy. Particular attention will be paid to responsible AI adoption, the new EU pharmaceutical legislation and the implications of AI for legal and professional practice.